CASP4 and melanoma: CASP4, an inflammatory caspase [19], has previously been associated with Apo2L/TRAIL sensitivity in melanoma [20] and rheumatoid arthritis synovial fibroblasts [21], but otherwise is not widely associated with DR5 signaling and thus was an unexpected finding.